Tumor-derived CCL5 does not contribute to breast cancer progression

Breast Cancer Research and Treatment

Volumn 111, Issue 3, 2008, Pages 511-521

  Jayasinghe, Mevan M ^a   Golden, Jacqueline M ^a   Nair, Priyanka ^a   O'Donnell, Cara M ^a   Werner, Michael T ^a   Kurt, Robert A ^a  

^a LAFAYETTE COLLEGE   (United States)

Author keywords

4T1; Breast cancer; CCL5; Chemokines; Metastasis

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RANTES; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER GROWTH; GENETIC TRANSFECTION; GROWTH RATE; IMMUNOMODULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINE CCL5; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCOMPATIBILITY ANTIGENS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION;

EID: 51649098196     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9802-6     Document Type: Article

References (45)

1. TJ Schall J Jongstra BJ Dyer J Jorgensen C Clayberger MM Davis AM Krensky 1988 A human T cell-specific molecule is a member of a new gene family J Immunol 141 1018 1025
2. TJ Schall K Bacon KJ Toy DV Goeddel 1990 Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES Nature 347 669 671
3. SJ Roth MW Carr TA Springer 1995 C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-gamma inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes Eur J Immunol 25 3482 3488
4. G de la Rosa N Longo JL Rodriguez-Fernandez A Puig-Kroger A Pineda AL Corbi P Sanchez-Mateos 2003 Migration of human blood dendritic cells across endothelial cell monolayers: adhesion molecules and chemokines involved in subset-specific transmigration J Leukoc Biol 73 639 649
5. DD Taub TJ Sayers CR Carter JR Ortaldo 1995 Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis J Immunol 155 3877 3888
6. Y Kameyoshi A Dorschner AI Mallet E Christophers JM Schroder 1992 Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils J Exp Med 176 587 592
7. P Conti X Pang W Boucher R Letourneau M Reale RC Barbacane J Thibault TC Theoharides 1997 RANTES is a pro-inflammatory chemokine and chemoattracts basophil cells to extravascular sites J Pathol 183 352 358
8. V Appay PR Dunbar V Cerundolo A McMichael L Czaplewski S Rowland-Jones 2000 RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation Int Immunol 12 1173 1182
9. TJ Cridge KM Horowitz MN Marinucci KM Rose M Wells MT Werner RA Kurt 2006 Functional and molecular alterations in T cells induced by CCL5 Immunol Invest 35 115 132
10. C Bandeira-Melo M Phoofolo PF Weller 2001 Extranuclear lipid bodies, elicited by CCR3-mediated signaling pathways, are the sites of chemokine-enhanced leukotriene C4 production in eosinophils and basophils J Biol Chem 276 22779 22787
11. M Locati U Deuschle ML Massardi FO Martinez M Sironi S Sozzani T Bartfai A Mantovani 2002 Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes J Immunol 168 3557 3562
12. TC Yao ML Kuo LC See LS Ou WI Lee CK Chan JL Huang 2006 RANTES and monocyte chemoattractant protein 1 as sensitive markers of disease activity in patients with juvenile rheumatoid arthritis: a six-year longitudinal study Arthritis Rheum 54 2585 2593
13. J Stanczyk ML Kowalski J Grzegorczyk B Szkudlinska M Jarzebska M Marciniak M Synder 2005 RANTES and chemotactic activity in synovial fluids from patients with rheumatoid arthritis and osteoarthritis Mediators Inflamm 2005 343 348
14. G McCormack D Moriarty DP O'Donoghue PA McCormick K Sheahan AW Baird 2001 Tissue cytokine and chemokine expression in inflammatory bowel disease Inflamm Res 50 491 495
15. A Ben-Baruch 2006 Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators Semin Cancer Biol 16 38 52
16. U Mrowietz U Schwenk S Maune J Bartels M Kupper I Fichtner JM Schroder D Schadendorf 1999 The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice Br J Cancer 79 1025 1031
17. CJ Moran DA Arenberg CC Huang TJ Giordano DG Thomas DE Misek G Chen MD Iannettoni MB Orringer S Hanash DG Beer 2002 RANTES expression is a predictor of survival in stage I lung adenocarcinoma Clin Cancer Res 8 3803 3812
18. GG Vaday DM Peehl PA Kadam DM Lawrence 2006 Expression of CCL5 (RANTES) and CCR5 in prostate cancer The Prostate 66 124 134
19. P Monti F Marchesi M Reni A Mercalli V Sordi A Zerbi G Balzano V Di Carlo P Allavena L Piemonti 2004 A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile Virchows Arch 445 236 247
20. G Luboshits S Shina O Kaplan S Engelberg D Nass B Lifshitz-Mercer S Chaitchik I Keydar A Ben-Baruch 1999 Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma Cancer Res 59 4681 4687
21. Y Niwa H Akamatsu H Niwa H Sumi Y Ozaki A Abe 2001 Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer Clin Cancer Res 7 285 289
22. N Yaal-Hahoshen S Shina L Leider-Trejo I Barnea EL Shabtai E Azenshtein I Greenberg I Keydar A Ben-Baruch 2006 The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients Clin Cancer Res 12 4474 4480
23. SC Robinson KA Scott FR Balkwill 2002 Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha Eur J Immunol 32 404 412
24. RA Kurt A Baher KP Wisner S Tackitt WJ Urba 2001 Chemokine receptor desensitization in tumor-bearing mice Cell Immunol 207 81 88
25. RA Kurt M Bauck S Harma E Adler P Vitiello KP Wisner S Tackitt WJ Urba 2003 Altered chemokine receptor sensitivity in FVBN202 rat neu transgenic mice Breast Cancer Res Treat 77 225 232
26. CL Aslakson FR Miller 1992 Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor Cancer Res 52 1399 1405
27. FR Miller BE Miller GH Heppner 1983 Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumor: heterogeneity in phenotypic stability Invasion Met 3 22 31
28. SM Elbashir W Lendeckel T Tuschl 2001 RNA interference is mediated by 21- and 22-nucleotide RNAs Genes Dev 15 188 200
29. TR Brummelkamp R Bernards R Agami 2002 A system for stable expression of short interfering RNAs in mammalian cells Science 296 550 553
30. PJ Paddison AA Caudy E Bernstein GJ Hannon DS Conklin 2002 Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells Genes Dev 16 948 958
31. SAL Eissa SA Zaki SM El-Maghraby DY Kadry 2005 Importance of serum IL-18 and RANTES as markers for breast carcinoma progression J Egypt Natl Canc Inst 17 51 55
32. S Ali J Kaur KD Patel 2000 Intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and regulated on activation normal T cell expressed and secreted are expressed by human breast carcinoma cells and support eosinophil adhesion and activation Am J Pathol 157 313 321
33. E Azenshtein G Luboshits S Shina E Neumark D Shahbazian M Weil N Wigler I Keydar A Ben-Baruch 2002 The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity Cancer Res 62 1093 1102
34. SC Robinson KA Scott JL Wilson RG Thompson AEI Proudfoot FR Balkwill 2003 A chemokine receptor antagonist inhibits experimental breast tumor growth Cancer Res 63 8360 8365
35. EP Adler CA Lemken NS Katchen RA Kurt 2003 A dual role for tumor-derived RANTES (CCL5) Immunol Lett 90 187 194
36. KA Stormes CA Lemken JV Lepre MN Marinucci RA Kurt 2005 Inhibition of metastasis by inhibition of tumor-derived CCL5 Breast Cancer Res Treat 89 209 212
37. E Azenshtein T Meshel S Shina N Barak I Keydar A Ben-Baruch 2005 The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors Cancer Lett 217 73 86
38. S Shahrara CC Park V Temkin JW Jarvis MV Volin RM Pope 2006 RANTES modulates TLR4-induced cytokine secretion in human peripheral blood monocytes J Immunol 177 5077 5087
39. V Appay SL Rowland-Jones 2001 RANTES: a versatile and controversial chemokine Trends Immunol 22 83 87
40. B Bottazzi N Polentarutti R Acero A Balsari D Boraschi P Ghezzi M Salmona A Mantovani 1983 Regulation of the macrophage content of neoplasms by chemoattractants Science 220 210 212
41. B Bottazzi F Colotta A Sica N Nobili A Mantovani 1990 A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF) Int J Cancer 45 795 797
42. PF Vitiello MG Shainheit EM Allison EP Adler RA Kurt 2004 Impact of tumor-derived CCL2 on T cell effector function Immunol Lett 91 239 245
43. MS Brault RA Kurt 2005 Impact of tumor-derived CCL2 on macrophage effector function J Biomed Biotech 1 37 43
44. M Westby E van der Ryst 2005 CCR5 antagonists: host-targeted antivirals for the treatment of HIV infection Antivir Chem Chemother 16 339 354
45. M Baba K Takashima H Miyake N Kanzaki K Teshima X Wang M Shiraishi Y Iizawa 2005 TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans Antimicrob Agents Chemother 49 4584 4591